About this Journal Submit a Manuscript Table of Contents
Lung Cancer International
Volume 2012 (2012), Article ID 354657, 6 pages
http://dx.doi.org/10.1155/2012/354657
Clinical Study

Treatment of Non-Small-Cell Lung Cancer with Erlotinib following Gefitinib-Induced Hepatotoxicity: Review of 8 Clinical Cases

1Department of Thoracic Oncology, National Hospital Organization Toneyama National Hospital, 5-1-1 Toneyama, Toyonaka, Osaka 560-8552, Japan
2Pharmaceutical Department, National Hospital Organization Toneyama National Hospital, Toyonaka, Osaka, Japan

Received 15 May 2012; Revised 4 October 2012; Accepted 8 October 2012

Academic Editor: Ladislav Tomasek

Copyright © 2012 Yukihiro Yano et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Yukihiro Yano, Yoshinobu Namba, Masahide Mori, et al., “Treatment of Non-Small-Cell Lung Cancer with Erlotinib following Gefitinib-Induced Hepatotoxicity: Review of 8 Clinical Cases,” Lung Cancer International, vol. 2012, Article ID 354657, 6 pages, 2012. doi:10.1155/2012/354657